Katalin "Kati" Karikó is a Hungarian-American biochemist who specializes in ribonucleic acid-mediated mechanisms, particularly in vitro-transcribed messenger RNA for protein replacement therapy. From Wikipedia
Termination of 22 NIH-backed projects has sparked warnings that U.S. pandemic defense capacity may erode, risking a shift of biomedical innovation overseas.
